oxybutynin has been researched along with Psoriasis in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noe, MH | 1 |
| Shin, DB | 1 |
| Wehner, MR | 1 |
| Margolis, DJ | 1 |
| Gelfand, JM | 1 |
| Lee, JH | 1 |
| Jung, YS | 1 |
| Kim, GM | 1 |
| Bae, JM | 1 |
1 trial available for oxybutynin and Psoriasis
| Article | Year |
|---|---|
A hyaluronic acid-based microneedle patch to treat psoriatic plaques: a pilot open trial.
Topics: Adult; Aged; Dermatologic Agents; Drug Administration Schedule; Female; Humans; Hyaluronic Acid; Mal | 2018 |
1 other study available for oxybutynin and Psoriasis
| Article | Year |
|---|---|
Opioid prescribing in adults with and without psoriasis.
Topics: Administration, Oral; Adult; Aged; Analgesics, Opioid; Chronic Pain; Dermatologic Agents; Drug Presc | 2020 |